Kinase profiling in early stage drug discovery: sorting things out

Publication date: November 2015 Source:Drug Discovery Today: Technologies, Volume 18 Author(s): Olivier Defert, Sandro Boland Protein kinases represent one of the largest superfamilies of drugable targets and a major research area for both the pharmaceutical industry and academic groups. This has resulted in the emergence of numerous screening technologies and services dedicated to kinase profiling. In spite of this plentiful offering, the field is not without its own pitfalls, as the profusion of reported conditions and data can ultimately complicate interpretation of project results. Here, we discuss how kinase profiling was used in our early stage drug discovery efforts, from the perspective of a smaller biotech relying largely on assay outsourcing.
Source: Drug Discovery Today: Technologies - Category: Drugs & Pharmacology Source Type: research